Orbis Diagnostics Limited
- | Diagnostics
Orbis is developing a laboratory-accurate point-of-care blood diagnostics platform that is robust, inexpensive, and rapid (30 minutes or less). Our first panel contains the triplex of Hepatitis B Virus diagnostic tests called for by the CDC for screening of all US adults. We are offering the opportunity to invest at Pre-Series A or Series A stages. Our product is at TRL-4, the Design Verification stage-gate. 2025 will include two pilot studies and a beginning of our US clinical trial.
Address
AucklandNew Zealand
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}